ICICI Prudential Life’s stock is trading at 2.4 times P/EV for FY22, which appears reasonable given the growth levers. It’s trading at a significant valuation discount to HDFC Life. The valuation gap with HDFC Life will narrow only on the acceleration of business growth. Can business transformation pave the way for growth and offer upside to the current stock price? Watch the video to know
Shakti Pumps, which was hit by low market demand led by Covid-19 issues and slow government capex, has once again started seeing recovery in demand. While the ongoing market correction dented the stock price, export business continues to improve, and domestic markets have also witnessed growth. MC Pro suggests holding the stock as it currently seems to be trading at reasonable valuations. Watch the video to know if you should invest at current levels.
Demand for pig iron softened from mid-May, while prices witnessed a sharp drop after the imposition of export duty on steel by the government on May 22. The spread for pig iron turned negative for the first time in the last 10 years. In light of that and soaring raw material prices, Tata Metaliks' performance continues to be dismal. Should you still consider investing in the stock? Watch the video to find out
Thangamayil Jewellery mentions in its annual report that June’22 quarter was its best ever quarter in history. While the stock has corrected by about 25 percent in the past six months, market share gains from unorganised players provides a huge growth opportunity. MC Pro recommends long-term investors to add the stock to their portfolio. Here's why!
Grauer and Weil's stock has nosedived from Rs 84 in May’22 to the current level of around Rs 59 per share. It is currently trading at 12 times its FY24 estimated earnings. Considering that the valuation is now attractive and the business is improving, MC Pro sees a good opportunity to invest. Here's why
Despite a robust financial performance in recent quarters, shares of Polycab India have traded sideways for the past 12 months. At the current market price, the stock is valued at 30 times FY23 projected earnings. Should you enter at the current levels? Watch the video to find out
Avenue Supermarts (D-Mart) posted a better than anticipated Q1 result. Being the first normal quarter post COVID-led disruptions, Q1 saw sales pick-up in both old and newly-added stores. Both gross and EBIDTA margin performance was ahead of estimates reaching Pre-COVID levels seen in Q1FY20. The stock is trading at P/E of 71x FY24e, which is lower than its medium-term historical average range seen prior to COVID-19. Should you invest at current level? Watch the video to find out
Uflex is well-positioned to catapult into the next growth phase given resilient end-markets and sustainable manufacturing initiatives. MC Pro suggests investors to consider it as a long-term buying opportunity. Should you buy? Watch the video to find out.
Bajaj Healthcare is trading at eye-catching valuations post the recent correction. While the stock has corrected meaningfully, the company's business's positives and negatives are well-balanced at current market valuations which are 11.6 times FY23 earnings. The company continues to show progress across multiple dimensions even though it ended FY22 on a mixed note. Moreover, with the company nearing the completion of its capex phase, it could see a gradual reduction in debt over FY23/24.
Krishna Institute of Medical Sciences (KIMS) has a proven record of capturing unmet institutional healthcare needs in the hinterland, and turning around the operational metrics of the acquired assets. Management has stated that volumes have gradually picked up post the Omicron wave earlier this year. What remains to be seen is how its strategy of expanding into the tier 2/3 cities will pan out. MC Pro suggests accumulating the stock in current weak phase of the market. Here’s why
Indian Energy Exchange (IEX) is among the high-quality growth stocks that got sharply corrected in the last month. From its peak of around Rs.295 in December 2021 to current levels of around Rs.160 per share, the stock has fallen by 46 percent. While overall correction in the stock market was partly responsible, its high valuation was a key concern in the past. Should you invest in the company post recent consolidation? Watch the video to find out
The long-term structural growth story of the life insurance sector remains intact. Life insurers have increased their focus on the protection segment, which is a key theme for the life insurance sector. And as the share of protection products continues to increase, there exists scope for further margin expansion. So given the promising sector outlook, which life insurance company’s stock is a worthy investment consideration at this juncture? Watch the video to find out.
At the current market price, Home First Finance is trading at 3.1 times FY24e book value. For an HFC with strong earnings growth potential, valuations seem quite reasonable. But is it the right time to invest? Watch the video to find out
Post 45 percent correction from all-time high, Clean Science and Technologies’ valuations appear reasonable. While it the stock trades at a premium vs the sector, MC Pro believes it can sustain due to process efficiency and the emphasis on green chemistry. Should you invest in the stock? Watch the video to know more.
With a strong end to FY22 for Persistent Systems, marked by superior execution, strong defence of margin, and traction in order book, we tell you why there’s little doubt that FY23 would also be a good year for the company despite macro headwinds and fear of reduction in tech budgets.
Relaxo Footwears’ volumes dropped last fiscal owing to a steep increase in raw material prices, GST rate increase as well as channel destocking. However, MC Pro expects Relaxo’s margins to improve in FY23. Watch the video to find out why investors should utilise market weakness to add the stock in the portfolio.
Zomato’s share price came under pressure after the announcement of the Blinkit acquisition. While the deal awaits shareholders’ approvals, MC Pro believes intense competition in the food-delivery ecosystem may increase cash burn and losses. Watch the video to know more.
Sastasundar Ventures' stock has plunged over 50 percent from its all-time high in November’21, even though the business remains largely unaffected by ongoing market condition. MC Pro suggests growth outlook appears very promising from a long-term standpoint. Watch the video to find out why.
With the rising prevalence of chronic diseases and growth of biologics, MC Pro recommends holding Gland Pharma. Post the recent correction and downward adjustments in estimates, Gland Pharma is trading at 17x EV/EBITDA for FY24e. Here’s why it makes for a good investment bet.
With demand for security services and facility management set to rise as the economy reopens, should one buy SIS shares? Watch the video to know more.
Construction companies (excluding Dilip Buildcon) maintained double-digit growth momentum in Q4FY22. However, growth momentum moderated owing to government ban on construction activities in the NCR, slower execution by construction companies due to steep increase in raw material prices, and relatively higher base in the corresponding quarter last year. But MC Pro conviction stocks posted better execution with revenues growing 17% YoY. Watch the video to know which are these stocks.
After a staggering rally, the stock of BSE has seen a dramatic decline of 38 percent in the past three months amid market wide sell-off. Given the fast-deteriorating macro environment, why invest in BSE – a proxy for capital markets? Watch the video to find out
Semiconductor shortage coupled with rising raw material prices continues to impact Sona BLW’s performance. However, it is one of the rare gems in the listed space to play on the megatrends of electrification of vehicles. Watch the video to know more.
City Union Bank’s stock has corrected 28% from the peak. Valuation has moderated to 1.2 times book value estimated for FY24, way lower than its three-year historical average of 2.6 times, and peak valuation of 3.8 times book value. Is it time to buy the stock? Watch the video.
Fiem Industries posted a strong set of numbers in Q4FY22, despite significant demand weakness in the two-wheeler industry and commodity-linked cost pressure. Want to know why MC Pro recommends the stock? Watch the video to find out